US 10925879
Methods of treating developmental disorders and/or seizure disorders with etifoxine
granted A61KA61K31/536A61P
Quick answer
US patent 10925879 (Methods of treating developmental disorders and/or seizure disorders with etifoxine) held by OVID THERAPEUTICS INC. expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- OVID THERAPEUTICS INC.
- Grant date
- Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K31/536, A61P, A61P25/00, A61P25/22